YU47973B - S-enantiomerni glutaramidi i postupak za njihovo dobijanje - Google Patents

S-enantiomerni glutaramidi i postupak za njihovo dobijanje

Info

Publication number
YU47973B
YU47973B YU102289A YU102289A YU47973B YU 47973 B YU47973 B YU 47973B YU 102289 A YU102289 A YU 102289A YU 102289 A YU102289 A YU 102289A YU 47973 B YU47973 B YU 47973B
Authority
YU
Yugoslavia
Prior art keywords
glutaramides
enantiomeric
procedure
obtaining
enantiomer
Prior art date
Application number
YU102289A
Other languages
English (en)
Serbo-Croatian (sh)
Other versions
YU102289A (en
Inventor
J.C. Danilewicz
M.T. Williams
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of YU102289A publication Critical patent/YU102289A/xx
Publication of YU47973B publication Critical patent/YU47973B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Cosmetics (AREA)
YU102289A 1988-05-19 1989-05-18 S-enantiomerni glutaramidi i postupak za njihovo dobijanje YU47973B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888811873A GB8811873D0 (en) 1988-05-19 1988-05-19 Therapeutic agents

Publications (2)

Publication Number Publication Date
YU102289A YU102289A (en) 1991-06-30
YU47973B true YU47973B (sh) 1996-08-13

Family

ID=10637176

Family Applications (1)

Application Number Title Priority Date Filing Date
YU102289A YU47973B (sh) 1988-05-19 1989-05-18 S-enantiomerni glutaramidi i postupak za njihovo dobijanje

Country Status (29)

Country Link
EP (1) EP0342850B1 (enExample)
JP (1) JPH072699B2 (enExample)
KR (1) KR920000561B1 (enExample)
CN (1) CN1015361B (enExample)
AT (1) ATE76399T1 (enExample)
AU (1) AU602813B2 (enExample)
CA (1) CA1331197C (enExample)
CS (1) CS274502B2 (enExample)
DD (1) DD283772A5 (enExample)
DE (1) DE68901582D1 (enExample)
DK (1) DK172032B1 (enExample)
EG (1) EG19007A (enExample)
ES (1) ES2037418T3 (enExample)
FI (1) FI93541C (enExample)
GB (1) GB8811873D0 (enExample)
GR (1) GR3004968T3 (enExample)
HU (1) HU205067B (enExample)
IE (1) IE60724B1 (enExample)
IL (1) IL90267A (enExample)
MX (1) MX16067A (enExample)
MY (1) MY104735A (enExample)
NO (1) NO173647C (enExample)
NZ (1) NZ229186A (enExample)
PH (1) PH26740A (enExample)
PL (1) PL154813B1 (enExample)
PT (1) PT90584B (enExample)
SU (1) SU1766251A3 (enExample)
YU (1) YU47973B (enExample)
ZA (1) ZA893696B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
ATE130292T1 (de) * 1993-09-22 1995-12-15 Pfizer Res & Dev Hydrierung.
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
RU2667643C2 (ru) 2012-08-24 2018-09-21 Новартис Аг Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
US20180311241A1 (en) 2015-10-29 2018-11-01 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제

Also Published As

Publication number Publication date
DE68901582D1 (de) 1992-06-25
JPH0222256A (ja) 1990-01-25
CA1331197C (en) 1994-08-02
MX16067A (es) 1993-10-01
ZA893696B (en) 1990-12-28
GB8811873D0 (en) 1988-06-22
EG19007A (en) 1994-11-30
DD283772A5 (de) 1990-10-24
IE60724B1 (en) 1994-08-10
SU1766251A3 (ru) 1992-09-30
JPH072699B2 (ja) 1995-01-18
HUT53596A (en) 1990-11-28
PT90584B (pt) 1994-09-30
PL279491A1 (en) 1989-11-27
FI93541B (fi) 1995-01-13
KR920000561B1 (ko) 1992-01-16
NZ229186A (en) 1990-10-26
CN1015361B (zh) 1992-02-05
IL90267A (en) 1993-08-18
ATE76399T1 (de) 1992-06-15
HU205067B (en) 1992-03-30
AU602813B2 (en) 1990-10-25
IL90267A0 (en) 1989-12-15
MY104735A (en) 1994-05-31
CS274502B2 (en) 1991-04-11
PL154813B1 (en) 1991-09-30
FI93541C (fi) 1995-04-25
ES2037418T3 (es) 1993-06-16
AU3490489A (en) 1989-11-23
KR900017993A (ko) 1990-12-20
IE891613L (en) 1989-11-19
FI892386A0 (fi) 1989-05-18
NO892002L (no) 1989-11-20
NO892002D0 (no) 1989-05-18
PH26740A (en) 1992-09-28
NO173647B (no) 1993-10-04
EP0342850A1 (en) 1989-11-23
FI892386L (fi) 1989-11-20
DK172032B1 (da) 1997-09-22
GR3004968T3 (enExample) 1993-04-28
EP0342850B1 (en) 1992-05-20
CS296589A2 (en) 1990-09-12
DK240889D0 (da) 1989-05-18
CN1037704A (zh) 1989-12-06
DK240889A (da) 1989-11-20
PT90584A (pt) 1989-11-30
YU102289A (en) 1991-06-30
NO173647C (no) 1994-01-12

Similar Documents

Publication Publication Date Title
YU48995B (sh) Derivati hinuklidina
ATE41739T1 (de) Feste orale dosierungsformulierungen von kardiovaskularen heilmitteln mit konstanter freisetzungsgeschwindigkeit.
PT584347E (pt) Compostos de xantina hidroxilados enantiomericos
ES541372A0 (es) Un procedimiento para la preparacion de un compuesto de 2-oxindol-1-carboxamida
PT97562A (pt) Processo para a preparacao de uma composicao farmaceutica contendo um nucleo de diclofenac ou de piroxicamo e um revestimento de cobertura de uma prostaglandina
YU47554B (sh) RACEMSKI I OPTIČKI AKTIVNI DERIVATI PIRIDO (1,2-a) PIRAZINA I NJIHOVI INTERMEDIJERI
NO913136L (no) Fremgangsmaate for fremstilling av et preparat for oeyedraaper
ES8802421A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
CA2083639A1 (en) Substituted phenyl phenol leukotriene antagonists
ES556864A0 (es) Procedimiento para la obtencion de benzopiranos sustituidos.
DK0590150T3 (da) (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat
YU47338B (sh) Novo jedinjenje 4-fluoro-2-// (4-metoksi-2-piridinil)metil-/sulfinil/- 1h-benzimidazol i postupak za njegovo dobijanje
YU47903B (sh) Postupak za pripremanje oralne formulacije za kontrolisano/produženo oslobadjanje buspirona i njegovih soli
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
MX16067A (es) Derivados de glutaramida espirosustituidos y procedimiento para su preparacion
ES2138100T3 (es) Procedimiento para la preparacion de 1,5-benzotiazepinas por ciclizacion de esteres aminicos.
ES2061712T3 (es) Nuevos derivados sustituidos de 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
MY102440A (en) Fungicidal pyridyl cyclopropane carboxamides.
ES509782A0 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol y etanodiol.
ES515761A0 (es) "un procedimiento para la preparacion de esteres de aminociclopentano".
MY117689A (en) A new process for the preparation of 3-n, n-dicycobutylamino-8-fluoro-3, 4-dihydro-2h-1-benzopyran-5-carboxamide
ATE158796T1 (de) Pharmazeutisch wirksame enantiomere
ES8800231A1 (es) Un procedimiento para la preparacion de una trans-octahidro-oxazolo 4,5-g quinolina
ES2004215A6 (es) Procedimiento para preparar quinazolinas tetraciclicas
IT1211138B (it) Composto antiipertensivo procedimento per la sua preparazione e relative composizioni farmaceutiche.